Ventyx Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €181.79M +28.6% -€97.71M -20.7% -53.7% +0.33 pp N/A N/A
    (estimated) €141.40M +516.7% -€123.26M -22.4% -87.2% +6.1 pp N/A N/A
    (estimated) €22.93M +∞% -€158.84M +13.2% -692.8% -6.9 pp N/A N/A
    (estimated) €0.00 +NaN% -€140.35M +33.8% N/A N/A N/A
    (estimated) €0.00 +NaN% -€104.93M -10.0% N/A N/A N/A
    €0.00 +NaN% -€116.55M -30.0% N/A -€112.68M -21.3% N/A
    €0.00 +NaN% -€166.45M +78.7% N/A -€143.20M +68.5% N/A
    €0.00 +NaN% -€93.12M +37.8% N/A -€84.96M +156.6% N/A
    €0.00 +NaN% -€67.60M +174.7% N/A -€33.11M +519.7% N/A
    €0.00 +NaN% -€24.61M +537.9% N/A -€5.34M +134.5% N/A
    €0.00 -€3.86M N/A -€2.28M N/A

    Notifications